As the NHS grapples with unprecedented demand, workforce pressures and growing elective backlogs, agentic automation is emerging as the key practical lever of choice.
One in eight adults (12.7%) who are infected with SARS-CoV-2 experience long COVID symptoms, including chest pain, difficulties breathing, painful muscles and more.
Black patients and female patients with heart failure who qualify as candidates for surgery have a lower chance of getting that operation than white patients or male patients.
Relapse presents a major barrier to recovery from substance use disorders, and sleep disruptions have long been associated with drug withdrawal and relapse.
Smokers or vapers prior to hospitalisation for COVID-19 were more likely to experience severe complications, and die from COVID-19, than their counterparts.
Doctors now must take mandatory training on female-specific health, as a new women’s health strategy pushes for more equal research and medical conduct between...
NHS cancer patients will be the first to experience drone chemotherapy, which furthers the NHS net zero strategy, as it cuts down travel time and distance.
Dr Hans Henri P. Kluge & Dr Natasha Azzopardi Muscat explain the importance of putting health at the heart of tourism, including a commitment made in this vein by Europe’s smallest countries to better health systems.
Two NHS trusts in England will collaborate with technology partner Sectra to deploy digital pathology services using cloud infrastructure
NHS trusts in East Suffolk and...
Patients who attend the same GP are more likely to build a trusted relationship with them, and take their advice – but only 52% of patients can revisit the same GP.
Supporting social care, the government have invested £150 million over the next 3 years to enable digital healthcare transformation, ranging from virtual wards to vaccine records on phones.
Ketil Widerberg, General Manager of Oslo Cancer Cluster, describes the complexities of implementing precision cancer medicine in Norway and suggests a way forward.
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.
